Literature DB >> 19301816

Role of the hydrogen bonding heteroatom-Lys53 interaction between the p38alpha mitogen-activated protein (MAP) kinase and pyridinyl-substituted 5-membered heterocyclic ring inhibitors.

Bassam Abu Thaher1, Pierre Koch, Verena Schattel, Stefan Laufer.   

Abstract

In the framework of investigating the role of heteroatoms in pyridinyl-substituted 5-membered (hetero)cycles as potential p38alpha MAP kinase inhibitor scaffolds, cyclopentene, pyrrole, furan, and imidazole analogues were synthesized and tested with respect to their ability to inhibit p38alpha MAP kinase. The vicinal pyridine/4-fluorophenyl pharmacophore was conserved, such as in the prototypical imidazole inhibitor SB203580. The strength of the HB interaction was calculated and compared to the biological data.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19301816     DOI: 10.1021/jm801467h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Combretastatin A-4 derivatives: synthesis and evaluation of 2,4,5-triaryl-1H-imidazoles as potential agents against H1299 (non-small cell lung cancer cell).

Authors:  Chih-Hua Tseng; Chi-Yi Li; Chien-Chih Chiu; Huei-Ting Hu; Chein-Hwa Han; Yeh-Long Chen; Cherng-Chyi Tzeng
Journal:  Mol Divers       Date:  2012-09-26       Impact factor: 2.943

2.  5-(4-Fluoro-phen-yl)-4-(4-pyrid-yl)-1,3-oxazol-2-amine.

Authors:  Pierre Koch; Dieter Schollmeyer; Stefan Laufer
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-03-24

3.  3D-QSAR and molecular docking studies on fused pyrazoles as p38α mitogen-activated protein kinase inhibitors.

Authors:  Ping Lan; Zhi-Jian Huang; Jun-Rong Sun; Wei-Min Chen
Journal:  Int J Mol Sci       Date:  2010-09-17       Impact factor: 5.923

4.  Single agents with designed combination chemotherapy potential: synthesis and evaluation of substituted pyrimido[4,5-b]indoles as receptor tyrosine kinase and thymidylate synthase inhibitors and as antitumor agents.

Authors:  Aleem Gangjee; Nilesh Zaware; Sudhir Raghavan; Michael Ihnat; Satyendra Shenoy; Roy L Kisliuk
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

5.  4-(4-Fluoro-phen-yl)-1-(4-nitro-phen-yl)-3-(pyridin-4-yl)-1H-pyrazol-5-amine.

Authors:  Bassam Abu Thaher; Pierre Koch; Dieter Schollmeyer; Stefan Laufer
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-02-10

6.  Ethyl 5-amino-3-(pyridin-4-yl)-1-(2,4,6-tri-chloro-phen-yl)-1H-pyrazole-4-carb-oxyl-ate dimethyl sulfoxide hemisolvate.

Authors:  Bassam Abu Thaher; Pierre Koch; Dieter Schollmeyer; Stefan Laufer
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-02-29

7.  4-(4-Fluoro-phen-yl)-1-phenyl-3-(pyridin-4-yl)-1H-pyrazol-5-amine.

Authors:  Bassam Abu Thaher; Pierre Koch; Dieter Schollmeyer; Stefan Laufer
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-02-10

8.  4-[5-Amino-4-(4-fluoro-phen-yl)-3-(pyridin-4-yl)-1H-pyrazol-1-yl]benzo-nitrile.

Authors:  Bassam Abu Thaher; Pierre Koch; Dieter Schollmeyer; Stefan Laufer
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-03

9.  Structural Optimization of a Pyridinylimidazole Scaffold: Shifting the Selectivity from p38α Mitogen-Activated Protein Kinase to c-Jun N-Terminal Kinase 3.

Authors:  Francesco Ansideri; Joana T Macedo; Michael Eitel; Ahmed El-Gokha; Dhafer S Zinad; Camilla Scarpellini; Mark Kudolo; Dieter Schollmeyer; Frank M Boeckler; Bärbel S Blaum; Stefan A Laufer; Pierre Koch
Journal:  ACS Omega       Date:  2018-07-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.